Ex-CBER Director Peter Marks (Greg Nash/Pool via AP Images)
June 25, 2025 05:00 PM EDT
R&D
Pharma

Ex-CBER chief Marks crit­i­cizes how FDA craft­ed its new Covid vac­cine frame­work

Max Bayer

Pharma Reporter

Pe­ter Marks, the for­mer head of the FDA’s Cen­ter for Bi­o­log­ics Eval­u­a­tion and Re­search, says that the way the agency un­veiled its new Covid-19 vac­cine …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Ex­clu­sive: FDA's Makary sought re­jec­tion of KalVista’s drug in an un­usu­al move by com­mis­sion­er, sources say

Trump’s CDC nom­i­nee side­steps Sen­ate grilling on con­tro­ver­sial changes

Re­built CDC pan­el will re­assess cu­mu­la­tive vac­cine ef­fects, old­er shots

Kymera inks deal with Gilead as part­ner­ship with Sanofi faces a switch-up

Bright­Gene seeks a part­ner for Zep­bound-beat­ing obe­si­ty shot

sponsored

Dig­i­tal Twins in GMP Man­u­fac­tur­ing: Shap­ing the Fu­ture of CPV with Aizon

A service from the Financial Times